A tumour-on-a-chip model featuring patient-derived glioblastoma cells, vascular endothelial cells and decellularized extracellular matrix from brain tissue can be used to identify patient-specific resistance to standard chemoradiotherapy.
- Hee-Gyeong Yi
- Young Hun Jeong
- Dong-Woo Cho